Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09
Tota J et al. – In a large case–control study with cases identified from centers across the UK and using data from the NHS database (collected between 1990 and 2008), investigators evaluated the effectiveness of cervical screening with Pap tests, with a particular focus on women aged 20–24 years. Screening of these young women had little or no effect on the rates of invasive cervical cancer up to 30 years of age. However, screening older women (aged 35–64 years) was shown to reduce cervical cancer risk by approximately 60–80%. This study suggests that the screening age can be safely raised to 25 years without causing harm. Along with the information from this study, policymakers should consider the harms of screening at different ages as well as the absolute rate of cervical cancer in screened and unscreened women of different ages.
Related Articles
State-Level Differences in Breast and Cervical Cancer Screening by Disability Status: United States, 2008
Women's Health Issues, 11/04/09
Relevance Score: 93%
Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/21/09
Relevance Score: 93%
Screening for cervical cancer among Israeli lesbian women
International Nursing Review, 11/17/09
Relevance Score: 88%
Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand?
International Journal of Epidemiology, 10/08/09
Relevance Score: 88%
A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females
BMC Public Health, 11/17/09
Relevance Score: 87%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
BMC Cancer, 12/20/09
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Cancer Research, 12/20/09
Adult-Type Granulosa Cell Tumors and FOXL2 Mutation
Cancer Research, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


